Daniel T. Hogan
FMC Corporation
4 Papers
117 Citations
Daniel T. Hogan is an academic researcher from FMC Corporation. The author has contributed to research in topics: Microcrystalline cellulose & Internal medicine. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Patent
Stabilizer compositions, frozen desserts containing the same and stabilizing method
Dale T. Bertrand,Daniel T. Hogan,Domingo C. Tuason +2 more
- 29 Sep 1995
TL;DR: A stabilizer composition useful for frozen desserts contains a water soluble hydrocolloid and microcrystalline cellulose coprocessed with an alginate salt complex.
45
Patent
Coprocessed microcrystalline cellulose stabilizer compositions, foods containing the same and stabilization method
Daniel T. Hogan,Dale T. Bertrand,Marlene T. Tuazon,Domingo C. Tuason +3 more
- 15 Dec 1995
TL;DR: A stabilizer composition, useful for reduced fat frozen desserts and whipped toppings, containing microcrystalline cellulose coprocessed with guar and carboxymethylcellulose was proposed in this article.
43
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
Amanda M. Johnson,Maria Barsky,Waseem Ahmed,Samantha Zullow,Jonathan S. Galati,Vipul Jairath,Neeraj Narula,Farhad Peerani,Benjamin H. Click,Elliot Coburn,ThucNhi T. Dang,Stephanie Gold,Manasi Agrawal,Rajat Garg,Manik Aggarwal,D Mohammad,Brendan P. Halloran,Gursimran Kochhar,Hannah Todorowski,Nabeeha Mohy Ud Din,James L. Izanec,Amanda Teeple,Christopher Gasink,Erik Muser,Zhijie Ding,Arun Swaminath,Komal Lakhani,Daniel T. Hogan,Samit K. Datta,Ryan C. Ungaro,Brigid S. Boland,Matthew Bohm,Monika Fischer,Sashidhar Sagi,Anita Afzali,Thomas A. Ullman,Garrett Lawlor,Daniel C. Baumgart,Shannon Chang,David Hudesman,Dana J. Lukin,Ellen Scherl,Jean-Frederic Colombel,Bruce E. Sands,Corey A. Siegel,Miguel Regueiro,William J. Sandborn,David H. Bruining,Sunanda V. Kane,Edward V. Loftus,Parambir S. Dulai +50 more
TL;DR: The greatest treatment effect of UST was seen in bio-naive patients, and dose escalation may recapture clinical response, with 40% of patients from a highly refractory cohort achieving clinical remission by 12 months.
40
Patent
Rapidly peptizable microcrystalline cellulose-based stabilizing agents
Domingo C. Tuason,Edward Selinger,Gregory R. Krawczyk,Christopher J. Sewall,Daniel T. Hogan +4 more
- 22 Sep 1999
TL;DR: In this article, the use and preparation of a rapidly peptizable stabilizing composition comprising attrited colloidal microcrystalline cellulose wetcake coprocessed and dried with iota-carrageenan is described.
29